medcareernews.com
LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER - MedCareer News
LYNPARZA RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ADVANCED OVARIAN CANCER Lynparza is the first PARP inhibitor approved in Japan Lynparza tablets approved as maintenance...